Optimal Revascularization Approach for Elderly MI Patients: Complete is Key
The FIRE trial presented at the European Society of Cardiology Congress 2023 showed that complete revascularization, as opposed to treating only the culprit lesion, reduced the risk of cardiovascular events, including death and myocardial infarction, in elderly patients aged 75 and older presenting with either STEMI or NSTEMI. The trial demonstrated that complete revascularization guided by functional testing was safe and beneficial in this population, challenging the current practice of treating only the culprit lesion. The results highlight the need to consider complete revascularization in older patients with multivessel disease and may lead to a shift in clinical practice towards a more comprehensive approach.